Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer

New England Journal of Medicine - Tập 379 Số 21 - Trang 2040-2051 - 2018
Luis Paz‐Ares1, Alexander Luft1, David Vicente1, Ali Tafreshi1, Mahmut Gümüş1, Julien Mazières1, Bárbara Hermes1, Filiz Çay Şenler1, Tibor Csöszi1, Andrea Fülöp1, Jerónimo Rafael Rodríguez‐Cid1, Joanna Y. Wilson1, Shunichi Sugawara1, Terufumi Kato1, Ki Hyeong Lee1, Ying Cheng1, Silvia Novello2, Balázs Halmos1, Xiaodong Li1, Gregory M. Lubiniecki1, Bilal Piperdi1, Dariusz Kowalski1, Keynote Investigators
1From Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center, Universidad Complutense and Ciberonc, Madrid (L.P.-A.), and Hospital Universitario Virgen Macarena, Seville (D.V.) - both in Spain; Leningrad Regional Clinical Hospital, St. Petersburg, Russia (A.L.); Wollongong Oncology and Wollongong Private Hospital, Wollongong, NSW, Australia (A.T.); Istanbul Medeniyet University Hospital, Istanbul (M.G.), and Ankara University, Ankara (F.Ç.Ş.) - both in Turkey; Centre Hospitalier Universitaire de Toulouse, Université Paul Sabatier, Toulouse, France (J.M.); Universitätsklinikum Tübingen, Tübingen, Germany (B. Hermes); Jász-Nagykun-Szolnok County Hospital, Szolnok (T.C.), and Országos Korányi TBC és Pulmonológiai Intézet, Budapest (A.F.) - both in Hungary; Oncology Center, Medica Sur Hospital, Mexico City (J.R.-C.); Humber River Regional Hospital, Toronto (J.W.); Sendai Kousei Hospital, Sendai (S.S.), and the Kanagawa Cancer Center, Yokohama (T.K.) - both in Japan; Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheong-ju, South Korea (K.H.L.); Jilin Cancer Hospital, Changchun, China (Y.C.); University of Turin, Orbassano, Italy (S.N.); Montefiore Medical Center-Albert Einstein College of Medicine, New York (B. Halmos); Merck, Kenilworth, NJ (X.L., G.M.L., B.P.); and the Maria Skłodowska-Curie Institute of Oncology, Warsaw, Poland (D.M.K.).
2Equipe Quantification en Imagerie Fonctionnelle

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1016/j.lungcan.2014.01.009

10.1016/j.jtho.2016.05.021

10.3389/fonc.2017.00050

10.1016/j.jtho.2017.11.111

10.1016/S1470-2045(15)00021-2

10.1056/NEJMoa1504627

10.1016/S0140-6736(15)01281-7

10.1056/NEJMoa1606774

10.1016/S0140-6736(16)32517-X

10.1200/JCO.2018.36.18_suppl.LBA4

10.1056/NEJMoa1801005

Edge SB, 2010, AJCC cancer staging manual., 7

10.1097/00000421-198212000-00014

10.1016/j.ejca.2008.10.026

10.1097/PAI.0000000000000408

10.1016/j.ejim.2014.07.002

10.1056/NEJMoa1613493

10.1200/JCO.2016.71.7629

10.1200/JCO.2018.36.18_suppl.LBA9000

10.1056/NEJMoa1801946

10.1200/JCO.2018.36.15_suppl.9001

10.1056/NEJMoa1501824

10.1016/S1470-2045(16)30498-3

10.1016/j.jtho.2017.09.431

10.1016/j.jtho.2018.08.004